Delivery Order SPE2DR25D1053-SPE2DR26FV977
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of January 22, 2026. The award was made on December 30, 2025, with performance to be executed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $2,369.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of December 24, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 3, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,447.18 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on May 30, 2025, with an ultimate completion date of June 23, 2025. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 25, 2025. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 19, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop in 10ml format, with a firm fixed price and an ultimate completion date of December 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract was competitively awarded without a set-aside designation under firm fixed-price terms, with an ultimate completion date of June 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $2,369.20 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by December 8, 2025. The delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a ceiling value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV977Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,369.20 to Amerisourcebergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will be executed in Conshohocken, Pennsylvania, with an ultimate completion date of February 24, 2026. This delivery order is a child contract executed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support mechanism for military healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor providing a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to federal agencies. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent organization, Cencora, Inc., holds a separate significant IDC with the DLA valued at up to $999,999,999.00 through December 2031, underscoring the critical role these entities play in supporting military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/1/26 |